Cannabis Bioscience International Holdings, Inc.
CBIH
$0.0008
$0.000114.29%
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 365.40K | 354.90K | 248.80K | 219.30K | 234.20K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 365.40K | 354.90K | 248.80K | 219.30K | 234.20K |
| Cost of Revenue | 37.90K | 45.20K | 45.60K | 51.70K | 64.00K |
| Gross Profit | 327.50K | 309.80K | 203.30K | 167.70K | 170.20K |
| SG&A Expenses | 674.40K | 691.50K | 664.20K | 873.90K | 1.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 712.30K | 736.70K | 709.80K | 925.60K | 1.07M |
| Operating Income | -346.80K | -381.70K | -460.90K | -706.20K | -831.10K |
| Income Before Tax | -500.90K | -545.80K | -651.30K | -791.40K | -906.90K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.50 | -0.55 | -0.65 | -0.79 | -0.91 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -500.90K | -545.80K | -651.30K | -791.40K | -906.90K |
| EBIT | -346.80K | -381.70K | -460.90K | -706.20K | -831.10K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 41.65B | 41.48B | 41.35B | 40.87B | 38.35B |
| Average Diluted Shares Outstanding | 41.65B | 41.48B | 41.35B | 40.87B | 38.35B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
